Lymphangiogenic factors are associated with the severity of hypersensitivity pneumonitis

BMJ Open Respiratory Research

Volumn 2, Issue 1, 2015, Pages 1-8

  Yamashita, Masahiro ^a   Mouri, Takashi ^a,b   Niisato, Miyuki ^a   Nitanai, Hiroo ^a   Kobayashi, Hitoshi ^a   Ogasawara, Masahito ^c   Endo, Ryujin ^a   Konishi, Kazuki ^d   Sugai, Tamotsu ^a   Sawai, Takashi ^a   Yamauchi, Kohei ^a  

^a IWATE MEDICAL UNIVERSITY   (Japan)

^b Iwate Prefectural Chubu Hospital   (Japan)

^c EHIME UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^d Morioka Tsunagi Onsen Hospital   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE RECEPTOR CCR7; PODOPLANIN; SECONDARY LYMPHOID TISSUE CHEMOKINE; VASCULOTROPIN A; VASCULOTROPIN C; VASCULOTROPIN D;

ADULT; AGED; ALLERGIC PNEUMONITIS; ARTICLE; BRONCHOALVEOLAR LAVAGE FLUID; CD4 CD8 RATIO; CLINICAL ARTICLE; CONTROLLED STUDY; DIFFUSION CAPACITY OF THE LUNG FOR CARBON MONOXIDE; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FIBROSING ALVEOLITIS; FORCED EXPIRATORY VOLUME; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LUNG FUNCTION TEST; LYMPH VESSEL ENDOTHELIUM; LYMPHANGIOGENESIS; LYMPHOCYTE COUNT; MACROPHAGE; MALE; MIDDLE AGED; PRIORITY JOURNAL; PROTEIN EXPRESSION; RETROSPECTIVE STUDY; TOTAL LUNG CAPACITY; VITAL CAPACITY;

EID: 85006965994     PISSN: None     EISSN: 20524439     Source Type: Journal    
DOI: 10.1136/bmjresp-2015-000085     Document Type: Article

References (36)

1. Selman M, Pardo A, King TE Jr. Hypersensitivity pneumonitis: insights in diagnosis and pathobiology. Am J Respir Crit Care Med 2012;186:314-24.
2. Hapke EJ, Seal RM, Thomas GO, et al. Farmer's lung. A clinical, radiographic, functional, and serological correlation of acute and chronic stages. Thorax 1968;23:451-68.
3. Lalancette M, Carrier G, Laviolette M, et al. Farmer's lung. Long-term outcome and lack of predictive value of bronchoalveolar lavage fibrosing factors. Am Rev Respir Dis 1993;148:216-21.
4. Cormier Y, Bélanger J, LeBlanc P, et al. Bronchoalveolar lavage in farmers' lung disease: diagnostic and physiological significance. Br J Ind Med 1986;43:401-5.
5. Hariri LP, Mino-Kenudson M, Shea B, et al. Distinct histopathology of acute onset or abrupt exacerbation of hypersensitivity pneumonitis. Hum Pathol 2012;43:660-8.
6. Kawanami O, Basset F, Barrios R, et al. Hypersensitivity pneumonitis in man. Light-and electron-microscopic studies of 18 lung biopsies. Am J Pathol 1983;110:275-89.
7. Coleman A, Colby TV. Histologic diagnosis of extrinsic allergic alveolitis. Am J Surg Pathol 1988;2:514-18.
8. Bhan U, Newstead MJ, Zeng X, et al. Stachybotrys chartarum-induced hypersensitivity pneumonitis is TLR9 dependent. Am J Pathol 2011;179:2779-87.
9. Blanchet MR, Bennett JL, Gold MJ, et al. CD34 is required for dendritic cell trafficking and pathology in murine hypersensitivity pneumonitis. Am J Respir Crit Care Med 2011;184:687-98.
10. Daito H, Kikuchi T, Sakakibara T, et al. Mycobacterial hypersensitivity pneumonitis requires TLR9-MyD88 in lung CD11b+ CD11c+ cells. Eur Respir J 2011;38:688-701.
11. Alitalo K. The lymphatic vasculature in disease. Nat Med 2011;17:1371-80.
12. Jeltsch M, Kaipainen A, Joukov V, et al. Hyperplasia of lymphatic vessels in VEGF-C transgenic mice. Science 1997;276:1423-5.
13. Karkkainen MJ, Haiko P, Sainio K, et al. Vascular endothelial growth factor C is required for sprouting of the first lymphatic vessels from embryonic veins. Nat Immunol 2004;5:74-80.
14. Achen MG, Jeltsch M, Kukk E, et al. Vascular endothelial growth factor D (VEGF-D) is a ligand for the tyrosine kinases VEGF receptor 2 (Flk1) and VEGF receptor 3 (Flt4). Proc Natl Acad Sci USA 1998;95:548-53.
15. Yamashita M, Iwama N, Date F, et al. Macrophages participate in lymphangiogenesis in idiopathic diffuse alveolar damage through CCL19-CCR7 signal. Hum Pathol 2009;40:1553-63.
16. Cursiefen C, Chen L, Borges LP, et al. VEGF-A stimulates lymphangiogenesis and hemangiogenesis in inflammatory neovascularization via macrophage recruitment. J Clin Invest 2004;113:1040-50.
17. Kriehuber E, Breiteneder-Geleff S, Groeger M, et al. Isolation and characterization of dermal lymphatic and blood endothelial cells reveal stable and functionally specialized cell lineages. J Exp Med 2001;194:797-808.
18. Yamashita M, Mouri T, Niisato M, et al. Heterogeneous characteristics of lymphatic microvasculatures associated with pulmonary sarcoid granulomas. Ann Am Thorac Soc 2013;10: 90-7.
19. Ålgars A, Karikoski M, Yegutkin GG, et al. Different role of CD73 in leukocyte trafficking via blood and lymph vessels. Blood 2011;117:4387-93.
20. Serra HM, Eberhard Y, Martín AP, et al. Secondary lymphoid tissue chemokine (CCL21) is upregulated in allergic contact dermatitis. Int Arch Allergy Immunol 2004;133:64-71.
21. Kerjaschki D, Regele HM, Moosberger I, et al. Lymphatic neoangiogenesis in human kidney transplants is associated with immunologically active lymphocytic infiltrates. J Am Soc Nephrol 2004;15:603-12.
22. Glasgow CG, Avila NA, Lin JP, et al. Serum vascular endothelial growth factor-D levels in patients with lymphangioleiomyomatosis reflect lymphatic involvement. Chest 2009;135:1293-300.
23. Xu KF, Zhang P, Tian X, et al. The role of vascular endothelial growth factor-D in diagnosis of lymphangioleiomyomatosis (LAM). Respir Med 2013;107:263-8.
24. Zhang Y, Meng X, Zeng H, et al. Serum vascular endothelial growth factor-C levels: a possible diagnostic marker for lymph node metastasis in patients with primary non-small cell lung cancer. Oncol Lett 2013;6:545-9.
25. Richerson HB, Bernstein IL, Fink JN, et al. Guidelines for the clinical evaluation of hypersensitivity pneumonitis. Report of the Subcommittee on Hypersensitivity Pneumonitis. J Allergy Clin Immunol 1989;84:839-44.
26. Gardner RM, Hankinson JL. Standardization of spirometry-1987 ATS update (American Thoracic Society). J Occup Med 1988;30:272-3.
27. Miller MR, Hankinson J, Brusasco V. Standardisation of spirometry. Eur Respir J 2005;26:319-38.
28. Meyer KC, Raghu G, Baughman RP, et al., American Thoracic Society Committee on BAL in Interstitial Lung Disease. An official American Thoracic Society clinical practice guideline: the clinical utility of bronchoalveolar lavage cellular analysis in interstitial lung disease. Am J Respir Crit Care Med 2012;185:1004-14.
29. Nykänen AI, Sandelin H, Krebs R, et al. Targeting lymphatic vessel activation and CCL21 production by vascular endothelial growth factor receptor-3 inhibition has novel immunomodulatory and antiarteriosclerotic effects in cardiac allografts. Circulation 2010;121:1413-22.
30. Travis WD, Matsui K, Moss JE, et al. Idiopathic nonspecific interstitial pneumonia: prognostic significance of cellular and fibrosing patterns. Survival comparison with usual interstitial pneumonia and desquamative interstitial pneumonia. Am J Surg Pathol 2000;24:19-33.
31. Katzenstein AL, Myers JL. Idiopathic pulmonary fibrosis: clinical relevance of pathologic classification. Am J Respir Crit Care Med 1998;157:1301-15.
32. Marchal-Sommé J, Uzunhan Y, Marchand-Adam S, et al. Dendritic cells accumulate in human fibrotic interstitial lung disease. Am J Respir Crit Care Med 2007;176:1007-14.
33. Pierce EM, Carpenter K, Jakubzick C, et al. Idiopathic pulmonary fibrosis fibroblasts migrate and proliferate to CC chemokine ligand 21. Eur Respir J 2007;29:1082-93.
34. Pierce EM, Carpenter K, Jakubzick C, et al. Therapeutic targeting of CC ligand 21 or CC chemokine receptor 7 abrogates pulmonary fibrosis induced by the adoptive transfer of human pulmonary fibroblasts to immunodeficient mice. Am J Pathol 2007;170:1152-64.
35. El-Chemaly S, Malide D, Zudaire E, et al. Abnormal lymphangiogenesis in idiopathic pulmonary fibrosis with insights into cellular and molecular mechanisms. Proc Natl Acad Sci USA 2009;106:3958-63.
36. Lara AR, Cosgrove GP, Janssen WJ, et al. Increased lymphatic vessel length is associated with the fibroblast reticulum and disease severity in usual interstitial pneumonia and nonspecific interstitial pneumonia. Chest 2012;142:1569-76.